These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China. Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272 [TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
9. Epirubicin, oxaliplatin, and capectabine is just as "MAGIC"al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer. Sirohi B; Barreto SG; Singh A; Batra S; Mittra A; Rastogia S; Ramadwar M; Shetty N; Goel M; Shrikhande SV J Cancer Res Ther; 2014; 10(4):866-70. PubMed ID: 25579520 [TBL] [Abstract][Full Text] [Related]
10. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy. Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience. Strickland AH; Karapetis CS; Yip D; Harper PG Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143 [No Abstract] [Full Text] [Related]
15. Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. Smyth EC; Fassan M; Cunningham D; Allum WH; Okines AF; Lampis A; Hahne JC; Rugge M; Peckitt C; Nankivell M; Langley R; Ghidini M; Braconi C; Wotherspoon A; Grabsch HI; Valeri N J Clin Oncol; 2016 Aug; 34(23):2721-7. PubMed ID: 27298411 [TBL] [Abstract][Full Text] [Related]
16. A nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors. Larsen AC; Holländer C; Duval L; Schønnemann K; Achiam M; Pfeiffer P; Yilmaz MK; Thorlacius-Ussing O; Bæksgaard L; Ladekarl M Ann Surg Oncol; 2015 May; 22(5):1540-7. PubMed ID: 25348777 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [TBL] [Abstract][Full Text] [Related]
18. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451 [TBL] [Abstract][Full Text] [Related]
19. [Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Gabbani M; Grandinetti A; Tomezzoli A; Ruzzenente A; Guglielmi A; de Manzoni G Chir Ital; 2005; 57(1):9-14. PubMed ID: 15832733 [TBL] [Abstract][Full Text] [Related]
20. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]